Published • loading... • Updated
Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor
- Harbour BioMed appointed Dr. Dhavalkumar Patel as a Scientific Advisor to its board.
- Dr. Jingsong Wang, CEO of Harbour BioMed, praised Dr. Patel's expertise in immunology and drug development as valuable to the company.
- Dr. Patel expressed honor in joining Harbour BioMed and highlighted the company's promising antibody portfolio targeting immune pathways.
- Harbour BioMed is a global biopharmaceutical company focused on discovering and developing novel antibody therapeutics in immunology, oncology, and related fields.
Insights by Ground AI
32 Articles
32 Articles
LoudounTimes.com+31 Reposted by 31 other sources
Harbour BioMed Appoints Dr. Dhavalkumar Patel as Scientific Advisor
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI, June 11, 2026 /PRNewswire/ -- Harbour BioMed (the "Company"; HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics in immunology, oncology and other disease areas, today announced…
Coverage Details
Total News Sources32
Leaning Left6Leaning Right4Center9Last UpdatedBias Distribution47% Center
Bias Distribution
- 47% of the sources are Center
47% Center
L 32%
C 47%
R 21%
Factuality
To view factuality data please Upgrade to Premium
